10x Genomics, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $71.1M |
| Cost of Revenue | $10.6M |
| Gross Profit | $60.5M |
| Gross Margin | 85.1% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $46.7M |
| Operating Income | $-18.4M |
| Operating Margin | -25.8% |
| Interest Expense | $811.0K |
| Pretax Income | $-18.7M |
| Income Tax Expense | $21.0K |
| Net Income | $-18.8M |
| Net Margin | -26.4% |
| EPS (Basic) | $-0.54 |
| EPS (Diluted) | $-0.54 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |